About H2 Pharma Consulting

H2 Pharma was founded in 2007 by two senior Pharmaceutical Development Specialists: Dr. Hiep Huatan and Jane Hua

Biography: Dr Hiep Huatan, PhD, BPharm (Hons), MRPharmS
Dr Hiep Huatan is a Pharmaceutical Development Consultant, Managing Director of H2 Pharma Consulting Limited and CEO of a specialty pharmaceutical company, D3 Pharma Limited.  He has over 20-years’ experience in pharmaceutical product development, specialising in the areas of biopharmaceutics, formulation development, process scale-up and regulatory CMC.  Hiep is presently Consultant to several pharmaceutical and medical device companies worldwide. He was previously Chief Development Officer at Diurnal Group plc, Vice-President of R&D at Phoqus Pharmaceuticals, and was Head of Formulation Development at Pfizer Global R&D.  He graduated in Pharmacy from the University of Nottingham (UK) and gained his PhD in Pharmaceutics from the University of Manchester (UK).  Hiep is a Pharmaceutical Chemist and registered member of the Royal Pharmaceutical Society of Great Britain. He is a leading authority on modified release drug delivery technologies and author of over 50 original publications, including patents, in the field of pharmaceutical formulation, biopharmaceutics, and process design.

Biography: Jane Hua, BPharm (Hons)
Jane Hua is a Clinical Research Consultant and Co-Director of H2 Pharma Consulting Limited. She was previously Clinical Project Director at Quintiles (UK) and Clinical Project Manager at Innovex, Icon and GSK (legacy Wellcome Foundation). Jane has extensive experience in clinical research and development spanning over 20-years within the Biotech, Pharmaceutical and Clinical Contract Research Organisations. She provides interim clinical project management support to pharmaceutical companies, working across a spectrum of small and large organisations, including Biotech start-ups and SMEs. Jane specialises in the set-up, management and quality provisions for the conduct of clinical studies from early phases of drug development through to pivotal studies and post-marketing trials. She has comprehensive and current knowledge of GCP and associated UK Specific Statutory requirements. Jane graduated in Pharmacy from the University of Nottingham (UK).